Oncohost

Oncohost is a clinical-stage precision oncology startup that combines life science research with advanced machine learning technology to develop personalized strategies for cancer patients. Current clinical trials focus on melanoma and non-small cell lung cancer (NSCLC) patients, with plans to expand to other indications soon. Its platform, PROphet, analyzes proteomic changes in patient blood samples, detects signs of resistance to cancer therapies in real time, provides biomarker-guided treatment planning for physicians, aids in target discovery for drug development, and ultimately improves patient outcomes.